Mechanistic Study of Dual-Function Inhibitors Targeting Topoisomerase II and Rad51-Mediated DNA Repair Pathway against Castration-Resistant Prostate Cancer

Scientists discovered the anti-CRPC effects and underlying mechanisms of small-molecule compounds targeting topoisomerase II and cellular components of DNA damage repair.